Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.

about

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.

Item

http://www.wikidata.org/entity/Q53678430

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Treatment gaps and potential c ...... tin use in the US and England.

@en

Treatment gaps and potential c ...... tin use in the US and England.

@nl

type

Item

label

Treatment gaps and potential c ...... tin use in the US and England.

@en

Treatment gaps and potential c ...... tin use in the US and England.

@nl

prefLabel

Treatment gaps and potential c ...... tin use in the US and England.

@en

Treatment gaps and potential c ...... tin use in the US and England.

@nl

P1476

Treatment gaps and potential c ...... tin use in the US and England.

@en

P2093

Goodarz Danaei

http://www.w3.org/2001/XMLSchema#string

Kazem Rahimi

http://www.w3.org/2001/XMLSchema#string

Philip Clarke

http://www.w3.org/2001/XMLSchema#string

Thomas Wai-Chun Lung

http://www.w3.org/2001/XMLSchema#string

Yuan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for the primary prevention of cardiovascular disease

Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

National trends in statin use by coronary heart disease risk category

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

P304

e0190688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0190688

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joshua A Salomon

Peter Ueda

P577

2018-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29561843

http://www.w3.org/2001/XMLSchema#string

P932

5862405

http://www.w3.org/2001/XMLSchema#string